Quick answer
EHL BIO maintains a network of over 100 partner hospitals in Korea, including top-tier university hospitals like Yonsei University and specialized plastic surgery clinics in Gangnam. These partnerships focus on clinical research and the development of stem cell therapies under high safety standards.
Key takeaways
- Collaborations with top university hospitals in Korea including Yonsei (Gangnam Severance) and Chungnam National University Hospital.
- Extensive network with premier plastic surgery and aesthetic centers like JK, id, and EU Hospitals in Gangnam and Apgujeong.
- Designated as the first official clinic-level Cell Therapy Research Institute (EHL Cell Clinic).
- Strategic partnerships covering clinical research and the development of next-generation cell therapies.
Vision for Medical Collaboration
EHL BIO is committed to building strategic alliances with leading medical institutions to continuously drive innovation in Regenerative Medicine. Currently, we maintain a network of over 100 partner hospitals in South Korea. These collaborations focus on technical knowledge exchange and robust cell culture technology for the goal of restoration and quality of life. Under the leadership of expert medical teams and scientists, EHL BIO has emerged as a biotech leader, seamlessly integrating healthcare with modern pharmaceutical innovation.
The core objective of this partner network is to realize the potential of stem cells and immune cells for age-related degeneration. The EHL Cell Center in Apgujeong serves as the primary hub for coordinating and delivering these advanced medical services.
Partnerships with University Hospitals and Research Institutes
EHL BIO has signed Memoranda of Understanding (MOU) and conducts clinical research with several renowned university hospitals in Korea, such as Gangnam Severance Hospital (Yonsei University), to promote medical innovation. Other key partners include Chungnam National University Hospital, Dankook University Hospital, and Chonnam National University Hospital. These collaborations focus on advanced regenerative medicine technologies for conditions requiring special care based on EHL team assessments.
Combining the clinical expertise of top-tier hospitals with EHL BIO’s patented technologies—such as high-purity urine-derived stem cell isolation and adipose-derived cell culture—enables research to surpass previous limitations. These efforts lead to government-backed clinical trials, further validating our safety and quality standards.
The synergy between EHL BIO and leading hospitals integrates advanced cell technology with medical expertise for the goal of best regenerative outcomes for you.
Network of Plastic Surgery and Aesthetic Clinics in Gangnam
In the field of aesthetics and surgery, EHL BIO partners with top-tier plastic surgery hospitals in Gangnam and Apgujeong, including JK, id, EU, and Yonsei Jayunmi Plastic Surgery, as well as specialized clinics like Leoncell and Well-aging. This partnership focuses on applying Adipose-derived Stem Cells and Exosomes for skin rejuvenation and holistic 'Aging Well' healthcare.
Additionally, EHL BIO collaborates with leading cosmetic and pharmaceutical manufacturers in Korea like Korean Colmar and Cosmax to develop products containing stem cell conditioned media certified by relevant Korean authorities. This extensive network ensures that clients receive care from specialized medical teams combined with EHL BIO’s superior cell technology.
Regulatory Compliance Under Modern Regenerative Medicine Act
All hospitals and clinics in EHL BIO’s network operate under the 'Advanced Regenerative Bio Act,' regulated by the Korean Ministry of Health and Welfare. EHL Cell Clinic was designated as the first official clinic-level Cell Therapy Research Institute, ensuring maximum transparency and safety in human cell management.
As the first entity in Korea to receive a Human Cell Management Business license, EHL BIO ensures the entire process—from cell collection and GMP-certified laboratory culture (Class 100) to delivery back to partner hospitals for restoration—is systematic and highly efficient. Our production system can handle up to 6,000 lots per year, supported by a research team of over 85 personnel dedicated to maintaining high quality-of-life standards for every client.
Frequently asked questions
How can patients access services at partner hospitals in Korea?
EHL Thailand provides a Thai coordination team to manage everything from initial consultation and medical assessment to travel planning for services at EHL Cell Clinic or appropriate partner hospitals tailored to each individual.
What are the safety standards of hospitals working with EHL BIO?
Network hospitals must be certified by the Korean Ministry of Health and Welfare and utilize cells cultured in EHL BIO's Class 100 GMP-certified center, ensuring high safety and excellent cell viability based on EHL team assessments.
What are the goals for restoration and quality of life at EHL BIO?
EHL BIO focuses on using cell technology to enhance quality of life and work towards the goal of restoring degenerated body parts to function more efficiently, through coordination between medical teams in Korea and Thailand.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.
